Completed Infection & Immunity Lungs & Breathing

The local immune response in the airways and blood of contacts early after TB exposure determines outcome

In plain English

AI plain-English summary

A simple blood test can reveal whether someone recently exposed to tuberculosis (TB) will go on to develop active disease or remain healthy. Most people infected with *Mycobacterium tuberculosis* never get sick, but doctors cannot predict who will progress to active TB. The critical immune events in the lungs and airways right after exposure remain a black box. This research aims to open that box by tracking immune changes in the airways and blood of recent TB contacts, comparing them with active TB patients in a low-TB-burden setting like the UK. If successful, this work could transform TB control. A reliable early-warning signature would allow clinicians to target preventive treatment only to those who truly need it, sparing the majority from unnecessary drugs. It would also reveal which immune responses protect against progression—information essential for designing better vaccines. Currently, the only TB vaccine, BCG, has variable efficacy. Understanding the local early immune response could guide the development of vaccines that trigger the right defences from the start, potentially cutting transmission chains before disease ever appears.

View original technical description
Most individuals infected with Mycobacterium tuberculosis remain healthy, while a subset only progress to active tuberculosis (TB) disease. Early local immune events following infection in humans, determining the pattern of ensuing host immunity and risk of disease progression, are unknown. We defined a blood transcriptional signature of active TB, absent in the majority of latently exposed asymptomatic individuals and healthy controls, that reflected the extent of radiographic lung disease. I recently demonstrated immunological heterogeneity in the blood transcriptome of a cohort of recent TB contacts. A small proportion expressed a persistent TB signature and subsequently progressed to active TB disease, whereas 50% of contacts who were sensitized to M. tuberculosis infection but did not progress to disease, exhibited a similar, but not identical, transient blood signature, suggesting early local immune responses are critical determinants of outcome from infection. I will now lead a study of TB contacts, to detect changes in immune events in the airways early after TB exposure, comparing with TB patients, in a low TB burden setting.The findings I will generate on the local early response to M. tuberculosis infection are critical for developing novel approaches for effective TB control and prevention and the improvement of vaccines.

View the original record at the funder ↗

Researchers

Anne O'garra (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Local immune response in airways and blood of contacts early after TB exposure
Investigating Early Immunological Events in Active TB Disease and Latent Tuberculosis Infection (EVENT TB)
Evaluating the Risk of Progression in Latent Tuberculosis Infection using Gene Transcription Signatures [Translate TB]
Molecular approaches to distinguish between latent and active tuberculosis and identify factors involved in protection.
Risk-stratification of TB infection

Original classification

Investigator Award in Science

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.